Finance

Lists
002332:SHE
Zhejiang Xianju Pharmaceutical Co Ltd
CNÂ¥8.65
+0.46%
(+0.040) 1D
Sep 28, 3:04:39 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002332...
Open
CNÂ¥8.63
High
CNÂ¥8.68
Low
CNÂ¥8.60
Mkt. cap
8.52B
Avg. vol.
13.37M
Volume
9.11M
Dividend
3.47%
Quarterly dividend
CNÂ¥0.08
Ex-dividend date
Sep 16, 2026
P/E ratio
22.17
52-wk high
CNÂ¥10.05
52-wk low
CNÂ¥7.92
EPS
CNÂ¥0.39
Shares outstanding
989.20M
No. of employees
3K
Open
CNÂ¥8.63
High
CNÂ¥8.68
Low
CNÂ¥8.60
Mkt. cap
8.52B
Avg. vol.
13.37M
Volume
9.11M
Dividend
3.47%
Quarterly dividend
CNÂ¥0.08
Ex-dividend date
Sep 16, 2026
P/E ratio
22.17
52-wk high
CNÂ¥10.05
52-wk low
CNÂ¥7.92
EPS
CNÂ¥0.39
Shares outstanding
989.20M
No. of employees
3K
About Zhejiang Xianju Pharmaceutical Co Ltd
CEO-
Employees3.21K
Founded1972
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
956.35M
933.39M
918.35M
1.04B
Cost of goods sold
352.15M
431.84M
372.24M
387.92M
Cost of revenue
352.15M
431.84M
372.24M
387.92M
Research and development expenses
72.48M
105.33M
69.00M
51.53M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
383.78M
401.84M
358.84M
387.70M
Operating expense
451.01M
521.61M
433.08M
455.99M
Total operating expenses
803.16M
953.45M
805.32M
843.91M
Operating income
153.19M
-20.06M
113.03M
196.38M
Other non operating income
-10.52M
7.42M
-6.08M
9.58M
EBT including unusual items
114.02M
78.49M
108.30M
181.44M
EBT excluding unusual items
146.48M
-13.00M
108.54M
199.76M
Income tax expense
14.25M
21.76M
17.93M
27.23M
Effective tax rate
12.50%
27.72%
16.56%
15.01%
Other operating expenses
-5.42M
14.84M
3.17M
8.72M
Net income
98.42M
42.96M
93.89M
150.67M
Net profit margin
10.29%
4.60%
10.22%
14.48%
Earnings per share
-
-
-
-
Interest and investment income
3.31M
4.04M
2.32M
3.99M
Interest expense
-1.59M
-1.42M
-725.41K
-626.06K
Net interest expenses
1.73M
2.62M
1.60M
3.37M
Depreciation and amortization charges
-
-
-
-
EBITDA
207.64M
33.50M
166.59M
252.42M
Gain or loss from assets sale
46.21M
-46.30M
-
107.13K
AI content may include mistakes. Learn more
Google apps